EMIT cannabinoid assay: confirmation by RIA and GC/MS

Area of Science:

• Forensic toxicology
• Analytical chemistry
• Immunoassays

Background:

• Marijuana use detection is crucial in clinical and forensic settings.
• Reliable and sensitive assays are needed for cannabinoid metabolite analysis in urine.
• Enzyme immunoassays offer a rapid screening method for drug use.

Purpose of the Study:

• To compare the qualitative performance of the EMIT Cannabinoid Assay against Radioimmunoassay (RIA) and Gas Chromatography/Mass Spectrometry (GC/MS).
• To assess the reliability, accuracy, precision, and recovery of the EMIT assay for detecting cannabinoids.
• To evaluate the EMIT assay's sensitivity and effectiveness in identifying marijuana use in a university student population.

Main Methods:

• Qualitative comparison of EMIT Cannabinoid Assay results with RIA and two GC/MS techniques.
• Assessment of assay reliability through accuracy, precision (coefficient of variation), and recovery studies.
• Analysis of 496 urine specimens to determine the prevalence of marijuana use.

Main Results:

• The EMIT Cannabinoid Assay demonstrated high agreement with RIA and GC/MS for positive samples.
• Precision studies showed coefficients of variation from 1.0-2.8% for response rates and ~30% for concentration units.
• The assay effectively discriminated between cannabinoid-negative and spiked urines at a 50 ng/mL detection limit.
• EMIT assay indicated potential higher sensitivity for cannabinoid metabolites compared to other methods.
• Approximately 25% of the studied university students showed evidence of casual marijuana use.

Conclusions:

• The EMIT Cannabinoid Assay provides reliable qualitative results for marijuana use detection.
• The assay's sensitivity and antibody heterogeneity offer advantages for routine screening of cannabinoid metabolites.
• The study highlights the utility of the EMIT assay in identifying drug use patterns within specific populations.